Exclusive chemotherapy for « early » glottic carcinoma. A 15 year experience;Cancers « limités » de l'étage glottique du larynx et chimiothérapie exclusive - 15 Ans d'expérience

Bulletin de l'Academie Nationale de Medecine

Volumn 181, Issue 4, 1997, Pages 641-649

  Laccourreye, Henri ^a   Binet, M Jacques Louis ^b   Binet, M Jean Paul ^b  

^a Hopital Laennec   (France)

^b NONE

Author keywords

Antineoplasic agents, combined; Cisplatin; Fluorouracil; Glottis; Laryngeal Neoplasms drug therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; GLOTTIS; HUMAN; LARYNX TUMOR; RETROSPECTIVE STUDY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0345728580     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. AMORNMARN R., PREMPREE T., VIRAVATHANA T. et al. - A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol, 1985, 24, 321-325.
2. SINHA P.P. - Radiation therapy in early carcinoma of the true vocal cords (Stage I and II). Int J Radiat Oncol Biol Phys, 1987, 13, 1635-1640.
3. HOWELL-BURKE D., PETERS L.J., GOEPFERT H. et al. - T2 glottic cancer recurrence, salvage, and survival after definite radiotherapy. Arch Otolaryngol Head Neck Surg, 1990, 116, 830-835.
4. LACCOURREYE O., WEINSTEIN G., TROTOUX J., BRASNU D., LACCOURREYE H. - Vertical partial laryngectomy : A critical analysis of local recurrence. Ann Otol Rhinol Laryngol, 1991, 100, 68-71.
5. BRASNU D., LACCOURREYE O., CHABARDES E., LACCOURREYE H. - Chirurgie conservatrice du larynx comme alternative à la laryngectomie totale après chimiothérapie néo-adjuvante. Ann Otolaryngol Chir Cervicofac. 1993, 110, 129-133.
6. BRASNU D., LACCOURREYE O., CHABARDES E. et al. - Laryngeal preservation following neoadjuvant chemotherapy, a preliminary study, in Johnson J.T., Didolkar M.S., (eds). Head and Neck Cancer (vol III). Amsterdam, New York. Excerpta Medica, 1993, pp 299-306.
7. The department of Veterans affairs laryngeal cancer study group. Induction chemotherapy plus radiation compared with surgery in patients with advanced laryngeal cancer. New Engl J Med, 1991, 324, 1685-1690.
8. DEMARD F., CHAUVEL P., SANTINI J. et al. - Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head & Neck, 1990, 12, 225-231.
9. KARP D.D., VAUGHAN C.W., CARTER R. et al. - Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long term follow-up report. Am J Clin Oncol, 1991, 14, 273-279.
10. VOKES E.E., WEICHSELBAUM R.R., LIPPMAN S.M. et al. - Head and neck cancer. New Engl J Med, 1993, 328, 184-194.
11. SHIRINIAN M.H., WEBER R.S., LIPPMAN S.M. et al. - Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer : The M.D. Anderson cancer center experience. Head & Neck, 1994, 16, 39-44.
12. SPAULDING M.B., FISHER S.T., WOLF G.T. et al. - Tumor response, toxicity and survival after neo-adjuvant organ preserving chemotherapy in advanced laryngeal cancer. J Clin Oncol, 1994, 12, 1592-1599.
13. LACCOURREYE O., WEINSTEIN G.S., BASSOT V., BRASNU D., LACCOURREYE H. - A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2. Cancer, 1994, 74, 2781-2790.
14. LACCOURREYE O., BASSOT V., BRASNU D., JOUFFRE V., MÉNARD M., LACCOURREYE H. - Chimiothérapie exclusive dans les cancers de la corde vocale T1-T3NO en réponse clinique complète après traitement néo-adjuvant cisplatine-fluorouracile. Presse Med, 1995, 24, 1337-40.
15. LACCOURREYE O., BRASNU D., BASSOT V., KHAYAT D., LACCOURREYE H. - Cisplatin-fluorouracil exclusive chemotherapy for T1-T3NO glottic squamous cell carcinoma complete clinical responders : five year results. J Clin Oncol, 1996, 14, 2331-36.
16. BEAHRS O.H., HENSON D.E., HUTTER R.V.P., MYERS M., eds. - American Joint Committee on Cancer, 3rd ed. Philadelphia : J.B. Lippincott, 1988, 39-44.
17. OKEN M.M., CREECH R.H., TORMEY D.C. et al. - Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 1982, 5, 649-655.
18. KAPLAN E.L., MEIER P. - Non parametric estimation from incomplete observations. J Am Stat Assoc, 1958, 53, 457-481.
19. JACOBS C., GOFFINET D.R., GOFFINET L. et al. - Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group. Cancer, 1987, 60, 1178-1183.
20. THYSS A., SCHNEIDER M., SANTINI J. et al. - Induction chemotherapy with cisplatinium and 5FU for squamous cell carcinoma of the head and neck. Br J Cancer, 1986, 54, 755-760.
21. JACOBS J.R., PAJAK T.F., KINZIE J. et al. - Induction chemotherapy in advanced head and neck cancer. A radiation therapy oncology group study. Arch Otolaryngol Head Neck Surg, 1987, 113, 193-197.
22. AL KOURAINY K., KISH J., ENSLEY J. et al. - Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer, 1987, 59, 233-238.
23. KIES M., KRAUT M., GORDON L. et al. - Improved survival and pretreatment characteristics of complete responders to combination chemotherapy in advanced head and neck cancer. Proc Am Soc Clin Oncol 2, 1983, 626, 160, (abstr).
24. NORRIS C.M., CLARK J.R., FREI E. et al. - Pathology of surgery after induction chemotherapy : an analysis of resectability and loco regional control. Laryngoscopy, 1986, 96, 292-302.
25. WOLF G.T., HONG W.K. - Induction therapy for organ preservation in advanced laryngeal cancer : is there a role. Head & Neck, 1995, 12, 279-283.
26. WOLF G.T., MAKUCH R.W., BAKER S.R. - Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous cell carcinoma. The head and neck contracts program. Cancer, 1984, 54, 2869-2877.
27. LACCOURREYE O., MIUSCATELLO L., BRASNU D., WEINSTEIN G.S. - Is supracricoid partial laryngectomy with cricohyoidoepiglottopexy a valuable alternative for T1 -T2 glottic carcinoma invading the anterior commissure. Am J Surg, 1997, sous presse.
28. LACCOURREYE H. - La chirurgie partielle des épithéliomas de l'étage glottique du larynx. Bull. Acad. Natle Med., 1993, 177, 1333-41.
29. VIANI L., STELL P.M., DALBY J.E. - Recurrence after radiotherapy for glottic carcinoma. Cancer, 1991, 67, 577-584.
30. HENDRICKSON F.R. - Radiation therapy treatment of larynx cancer. Cancer, 1991, 55, 2058-61.
31. LACCOURREYE O., BASSOT V., NAUDO P.H., JOUFFRE V., BRASNU D., LACCOURREYE H. - Chimiothérapie cisplatine-fluorouracile dans les cancers à point de départ glottique classés T2. Ann Otolaryngol Chir Cervicofac, 1994, 111, 281-291.
32. LACCOURREYE H., BONFILS P., BRASNU D. et al - Chimiothérapie et chirurgie partielle dans les épithéliomas du pharyngo-larynx. Ann Otolaryngol Chir Cervicofac, 1988, 105, 409-414.
33. LACAU ST GUILY J., BRASNU D., BASSOT V., CHEVALIER H., JACQUILLAT C., LACCOURREYE H. - Chimiothérapie d'induction des cancers des voies aéro-digestives supérieures. Analyse de la réponse tumorale chez 176 malades. Presse Med, 1985, 14, 1313-6.
34. WAGENFIELD S.H.J., HARWOOD A.R., BRYCE D.R. et al. - Second primary respiratory tract malignancies in glottic carcinoma. Cancer, 1980, 46, 1883-1886.
35. ROBERTS T.J., EPSTEIN B., LEE D.J. - Second neoplasms in patients with carcinoma of the vocal cord incidence and implications for survival. Int J Radiat Oncol Biol Phys, 1991, 21, 583-589.